GlaxoSmithKline settles healthcare fraud case for $3B
GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S. history. The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke U.S. laws in the marketing and development of pharmaceuticals.
- Sharp HealthCare Leaves Pioneer ACO Program
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Acute Kidney Injury Gets New Focus
- MA an Insurance Proving Ground for Providers
- States Without Medicaid Expansion Search for Alternatives
- Targeting Self-Insured Populations
- Interventional Radiology No Longer a Sub-Specialty
- mHealth Tackles Readmissions
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- NFP Hospitals' Revenue Growth at 'All-Time Low'